Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tolebrutinib for treating relapsing multiple sclerosis	Tolebrutinib (PRN-2246;SAR-442168)	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Topical rapamycin cream for treating facial angiofibroma	Topical rapamycin cream	Facial angiofibroma	Cardiovascular System , Dermatology , Genetic Disorders	2023	View \| Download
Toripalimab in combination with paclitaxel and cisplatin for treating advanced or metastatic oesophageal squamous cell cancer without previous systemic chemotherapy	Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Toripalimab		Head and Neck Cancer	2023	View \| Download
Toripalimab with chemotherapy for previously untreated recurrent or metastatic nasopharyngeal carcinoma	Chemotherapy , Toripalimab	Nasopharyngeal carcinoma	Head and Neck Cancer	2023	View \| Download
TransCon PTH for treating hypoparathyroidism	TransCon PTH	Hypoparathyroidism	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Trastuzumab deruxtecan neoadjuvant therapy for high-risk HER2-positive early stage breast cancer	Trastuzumab deruxtecan (DS-8201a; Enhertu)	Breast cancer	Breast Cancer	2023	View \| Download
Trastuzumab duocarmazine for third-line treatment of HER2-positive unresectable metastatic breast cancer	Trastuzumab duocarmazine	Breast cancer	Breast Cancer	2023	View \| Download
Tucatinib with trastuzumab and pertuzumab for maintenance treatment of unresectable locally advanced or metastatic HER2-positive breast cancer	Pertuzumab (Perjeta; R-1273) , Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380)	Breast cancer	Breast Cancer	2023	View \| Download
Upadacitinib for treating giant cell arteritis	Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate)	Giant cell arteritis	Cardiovascular System	2023	View \| Download
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children	Ustekinumab (Stelara; CNTO 1275; CNTO-1275)	Crohn's disease	Gastroenterology , Immunology	2023	View \| Download